SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 469 filers reported holding SEAGEN INC in Q3 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,776,646 | -26.5% | 41,370 | -33.3% | 0.50% | -24.5% |
| Q2 2023 | $11,942,335 | -51.5% | 62,051 | -48.9% | 0.67% | -54.6% |
| Q1 2023 | $24,605,977 | +67.5% | 121,529 | +6.3% | 1.48% | +45.6% |
| Q4 2022 | $14,690,621 | -1.4% | 114,315 | +5.0% | 1.01% | -2.5% |
| Q3 2022 | $14,902,000 | +4.1% | 108,909 | +34.6% | 1.04% | -3.6% |
| Q2 2022 | $14,318,000 | +23.8% | 80,918 | +0.8% | 1.08% | +63.6% |
| Q1 2022 | $11,561,000 | +44.1% | 80,256 | +54.7% | 0.66% | +61.9% |
| Q4 2021 | $8,022,000 | -8.5% | 51,889 | +0.5% | 0.41% | -14.7% |
| Q3 2021 | $8,765,000 | -14.9% | 51,619 | -20.9% | 0.48% | -15.9% |
| Q2 2021 | $10,300,000 | +8.0% | 65,241 | -5.0% | 0.57% | -1.6% |
| Q1 2021 | $9,538,000 | -23.9% | 68,689 | -4.0% | 0.58% | -21.3% |
| Q4 2020 | $12,532,000 | – | 71,557 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |